Brief: Rezolute Reports Positive Topline Results From Phase 2 Proof Of Concept Study Of Rz402

Rezolute

21/05/2024 21:51

May 21 (Reuters) - Rezolute Inc  RZLT.O :
    * REZOLUTE REPORTS POSITIVE TOPLINE RESULTS FROM PHASE 2
PROOF OF
CONCEPT STUDY OF RZ402 IN PATIENTS WITH DIABETIC MACULAR EDEMA
(DME)
    * MET PRIMARY STUDY ENDPOINTS: GOOD SAFETY PROFILE AND
REDUCTION
IN CENTRAL SUBFIELD THICKNESS (CST)
    * RZ402 WAS SAFE AND WELL-TOLERATED
    * NO SIGNIFICANT IMPROVEMENTS IN BCVA COMPARED TO PLACEBO

Source text for Eikon:  ID:nGNX8yrgvR 
Further company coverage:  RZLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))